A study of blood tests in young people with lupus
Part of Blood & lymphatic, Bones, joints & muscles, Immune system & allergy, Kidney & urinary, Skin clinical trials.
This study looks at blood test results in children and teenagers with lupus to see if they relate to how active the disease is or if it has caused long-term damage. It may help doctors better understand the disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been diagnosed with systemic lupus before your 18th birthday.
- Your diagnosis must meet the standard medical criteria for lupus (SLICC or ACR/EULAR).
- You cannot have started having lupus symptoms after age 18.
- You cannot have other long-term inflammatory or autoimmune diseases.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether two blood test markers (called T IgG and T IgM) can help doctors understand how active your lupus is and how much damage the disease has caused. If you join, your blood will be tested, and the results may help guide your treatment.
This study looks at a protein called CXCL5 in the blood of people with lupus and whether its level relates to how active the disease is. It is a simple blood test that might help doctors understand lupus activity better.
This study looks at early signs of heart disease in children and teens with lupus. It may help doctors understand how lupus affects the heart and blood vessels over time.
This study looks at blood test results in people with lupus compared to healthy people. It may help doctors understand lupus better and improve care.
This study aims to see if a blood test that measures a specific protein-related molecule can help doctors know how active your lupus is. If successful, this could lead to a simpler way to monitor the disease and adjust treatment.
This study looks at a type of immune cell in patients with active lupus. It may help doctors understand how lupus affects the immune system and could lead to better treatments.
Hear when a new Juvenile Systemic Lupus Erythematosus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.